T G Wendt

Summary

Affiliation: Friedrich Schiller University
Country: Germany

Publications

  1. ncbi request reprint Simultaneous radiochemotherapy versus radiotherapy alone in advanced head and neck cancer: a randomized multicenter study
    T G Wendt
    Department of Radiation Oncology, University of Munich, Germany
    J Clin Oncol 16:1318-24. 1998
  2. ncbi request reprint Thoracic radiotherapy in the treatment of limited disease of small-cell cancer: sequence and fractionation
    T G Wendt
    Department of Radiation Oncology, Friedrich Schiller University, Bachstrasse 18, D 07743, Jena, Germany
    Lung Cancer 33:S143-6. 2001
  3. ncbi request reprint Prognostic factors in squamous cell carcinoma of the head and neck
    T G Wendt
    Abteilung Strahlentherapie, Klinik für Radiologie, Friedrich Schiller Universitat Jena
    Onkologie 25:208-12. 2002

Collaborators

Detail Information

Publications3

  1. ncbi request reprint Simultaneous radiochemotherapy versus radiotherapy alone in advanced head and neck cancer: a randomized multicenter study
    T G Wendt
    Department of Radiation Oncology, University of Munich, Germany
    J Clin Oncol 16:1318-24. 1998
    ....
  2. ncbi request reprint Thoracic radiotherapy in the treatment of limited disease of small-cell cancer: sequence and fractionation
    T G Wendt
    Department of Radiation Oncology, Friedrich Schiller University, Bachstrasse 18, D 07743, Jena, Germany
    Lung Cancer 33:S143-6. 2001
    ..Different fractionation schedules and escalated total doses are tested prospectively in order to reduce the intrathoracic relapse rate. Increased intensity of intrathoracic radiotherapy seems to augment long term survival rates...
  3. ncbi request reprint Prognostic factors in squamous cell carcinoma of the head and neck
    T G Wendt
    Abteilung Strahlentherapie, Klinik für Radiologie, Friedrich Schiller Universitat Jena
    Onkologie 25:208-12. 2002
    ..Not all factors are relevant for all types of treatment. Besides ECS, these new factors so far have rarely been used to stratify prospective combined modality treatment according to the risk of locoregional and distant failure...